logo
NYSE:NVO logo

Novo Nordisk Community

NYSE:NVO Community
  • 7 Narratives written by author
  • 6 Comments on narratives written by author
  • 423 Fair Values set on narratives written by author
Create a narrative

Community Investing Ideas

NVO logo
Novo Nordisk
BE
Bejgal
Community Contributor

Novo Nordisk's Future Growth Driven by GLP-1 Market Expansion

Catalysts ◦ Strong position in the GLP-1 drug market , leading with Ozempic for diabetes and Wegovy for obesity. These products have driven significant growth.
View narrative
US$84.48
FV
19.3% undervalued intrinsic discount
12.20%
Revenue growth p.a.
37users have liked this narrative
0users have commented on this narrative
128users have followed this narrative
3 days ago author updated this narrative